Literature DB >> 30142425

The therapeutic effect of Ilex pubescens extract on blood stasis model rats according to serum metabolomics.

Di Cao1, Chuncao Xu2, Yuanyuan Xue1, Qingfeng Ruan1, Bao Yang1, Zhongqiu Liu1, Hui Cui1, Lei Zhang1, Zhongxiang Zhao3, Jing Jin4.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Ilex pubescens Hook. et Arn (MDQ), a traditional Chinese herb, is used in the treatment of cardiovascular diseases. However, the mechanisms underlying the preventive effect of MDQ on blood stasis remain unclear. AIM OF THE STUDY: In this study, serum metabolomics integrated with a biochemical assay strategy were established to evaluate the preventive effect and mechanism of action of MDQ on rats with acute blood stasis.
MATERIALS AND METHODS: Forty-nine rats were divided into seven groups: the control group, model group, aspirin treatment group (30 mg/kg), clopidogrel treatment group (8 mg/kg) and three MDQ treatment groups (250, 500 and 1000 mg/kg). A hybrid quadrupole time of flight mass spectrometry (QTOF/MS) coupled to ultra-high-performance liquid chromatography (UPLC) was applied for profiling the serum metabolites. The multivariate data analysis techniques using unsupervised principal component analysis (PCA) and supervised orthogonal projections to latent structures discriminant analysis (OPLS-DA) were used for pattern recognition and distinguishing variabilities among groups.
RESULTS: MDQ protected the rats against blood stasis, as evidenced by the restoration of the anti-platelet aggregation activity, fibrinogen concentration, prothrombin time, thrombin time, activated partial thromboplastin time, endothelial nitric oxide synthase, endothelin, thromboxane B2 and 6-keto-prostaglandin F1α. The combination of PCA and OPLS-DA revealed deviations in eighteen differential biomarkers in serum. The identified biomarkers were primarily engaged in the metabolic pathways including arachidonic acid metabolism, glycerophospholipid metabolism, phospholipid biosynthesis and bile acid biosynthesis. The levels of eleven biomarkers showed significant alterations and a tendency to be restored to normal values in MDQ-treated blood stasis rats. Moreover, a correlation network diagram was constructed to show the serum biomarkers perturbed by MDQ.
CONCLUSIONS: These results suggested that MDQ had preventive effects on blood stasis in rats via arachidonic acid metabolism and glycerophospholipid metabolism.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute blood stasis; Ilex pubescens; Metabolic phenotyping; UPLC-QTOF/MS

Mesh:

Substances:

Year:  2018        PMID: 30142425     DOI: 10.1016/j.jep.2018.08.026

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  4 in total

1.  Metabolomics Analysis of Laparoscopic Surgery Combined with Wuda Granule to Promote Rapid Recovery of Patients with Colorectal Cancer Using UPLC/Q-TOF-MS/MS.

Authors:  Tao Wang; Yihua Xu; Qicheng Chen; Weilin Zheng; Jie Wang; Haiping Zeng; Yuyan Wu; Lixing Cao; Zhiqiang Chen
Journal:  Evid Based Complement Alternat Med       Date:  2020-02-13       Impact factor: 2.629

2.  Combined Lipidomics and Network Pharmacology Study of Protective Effects of Salvia miltiorrhiza against Blood Stasis Syndrome.

Authors:  Yidian Jin; Zhiru Xie; Shasha Li; Xiangyu Zeng; Leqi Wang; Ping Hu; Hongyang Zhang; Xue Xiao
Journal:  Evid Based Complement Alternat Med       Date:  2021-03-19       Impact factor: 2.629

3.  Retracted Article: A high-throughput metabolomics strategy for discovering the influence of differential metabolites and metabolic pathways of huaxian capsules on sepsis-associated Qi deficiency and blood stasis syndrome.

Authors:  Qun Liang; Han Liu; Xiu-Li Li; Pei-Yang Sun; Yang Yang; Chunpeng Du
Journal:  RSC Adv       Date:  2019-09-30       Impact factor: 4.036

4.  Therapeutic Effect and Mechanism Study of Rhodiola wallichiana var. cholaensis Injection to Acute Blood Stasis Using Metabolomics Based on UPLC-Q/TOF-MS.

Authors:  Nan Ran; Zhiqiang Pang; Xuewa Guan; Guoqiang Wang; Jinping Liu; Pingya Li; Jingtong Zheng; Fang Wang
Journal:  Evid Based Complement Alternat Med       Date:  2019-11-03       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.